Alerts will be sent to your verified email
Verify Email
MEDICAMEQ
|
Medicamen Biotech
|
Prevest Denpro
|
Jenburkt Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.92 % | 19.0 % | 18.49 % |
|
5yr average Equity Multiplier
|
1.44 | 1.07 | 1.17 |
|
5yr Average Asset Turnover Ratio
|
0.55 | 0.6 | 0.88 |
|
5yr Avg Net Profit Margin
|
8.69 % | 29.64 % | 18.1 % |
|
Price to Book
|
1.92 | 4.63 | 2.73 |
|
P/E
|
49.51 | 27.26 | 15.11 |
|
5yr Avg Cash Conversion Cycle
|
49.75 Days | 42.6 Days | -32.02 Days |
|
Inventory Days
|
84.58 Days | 36.0 Days | 24.72 Days |
|
Days Receivable
|
139.4 Days | 44.41 Days | 48.38 Days |
|
Days Payable
|
264.75 Days | 39.32 Days | 82.6 Days |
|
5yr Average Interest Coverage Ratio
|
7.03 | 99.71 | 87.2 |
|
5yr Avg ROCE
|
10.34 % | 25.39 % | 24.44 % |
|
5yr Avg Operating Profit Margin
|
15.51 % | 36.91 % | 22.46 % |
|
5 yr average Debt to Equity
|
0.15 | 0.0 | 0.02 |
|
5yr CAGR Net Profit
|
-11.57 % | 2.94 % | 14.21 % |
|
5yr Average Return on Assets
|
4.73 % | 17.71 % | 15.8 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
40.46 % | 73.6 % | 46.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.75 % | 0.0 | 0.93 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Medicamen Biotech
|
Prevest Denpro
|
Jenburkt Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|